Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals. - Wikidata - wikimedia - TriplyDB

Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals.

Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals.

http://www.wikidata.org/entity/Q31097762

about

Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease Probing the aglycon promiscuity of an engineered glycosyltransferase In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.Assessing tumor hypoxia by positron emission tomography with Cu-ATSM Copper-64 Radiopharmaceuticals for Oncologic Imaging Unconventional nuclides for radiopharmaceuticals 2,2'-[Ethane-1,2-diylbis(-oxy)]dibenz-alde-hyde.Pharmacotherapeutic targets in Alzheimer's disease Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents.New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions.Positron emission tomography radiotracers for imaging hypoxia.A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.Synthesis, structure and biological evaluation of bis salicylaldehyde-4(N)-ethylthiosemicarbazone ruthenium(iii) triphenylphosphine.Fluorescence properties and cellular distribution of the investigational anticancer drug triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and its zinc(II) complex.Crystal structure of [butane-2,3-dione bis-(4-methyl-thio-semicarbazonato)-κ(4) S,N (1),N (1'),S'](pyridine-κN)zinc(II).A novel zinc bis(thiosemicarbazone) complex for live cell imaging.Synthetic, structural and kinetic studies on the binding of cyclohexane-1,2-bis(4-methyl-3-thiosemicarbazone) to divalent metal ions (Co, Ni, Cu, Zn or Cd).Nickel(ii) radical complexes of thiosemicarbazone ligands appended by salicylidene, aminophenol and aminothiophenol moieties.Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.Copper complexes with dissymmetrically substituted bis(thiosemicarbazone) ligands as a basis for PET radiopharmaceuticals: control of redox potential and lipophilicity.Halides tuning the subcellular-targeting in two-photon emissive complexes via different uptake mechanisms.Oxygen Sensing, Hypoxia Tracing and in Vivo Imaging with Functional Metalloprobes for the Early Detection of Non-communicable Diseases.The interplay of solvation, molecular conformation and supramolecular assembly in 1,1'-({[(ethane-1,2-diyl)dioxy](1,2-phenylene)}bis(methanylylidene))bis(thiosemicarbazide) and its N,N-dimethylformamide disolvate.Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics.

P2860

Q33480211-7BB7E6E6-D6AD-42FE-9E7C-409D6D2732E2 Q33870879-428BB58F-65C5-4BCB-8A7C-D006384F621C Q34235293-BC700DCF-35FF-42BA-8E89-BBDC1590B0BC Q35504360-4F1A921A-2BE2-463A-B779-1E853111378D Q35545523-4110FBC5-354A-402D-AC9B-83EBB197F141 Q35565683-29F20CB1-2C41-4DD6-B720-6A637FEC4BA4 Q37126530-C8AFCC53-C74E-4BA1-882C-A9259CA7DF7B Q37129181-06811FE1-EBB2-4001-9BCF-90906B7D82B9 Q37223064-F8257F06-3C5A-40E9-A322-41EB717D2590 Q37295067-CB235FC6-D723-424C-A108-621C6283B9F5 Q37827710-D7ED23B0-CBEA-4C1D-AAEB-6657757844F8 Q38040666-058CCB95-9EDA-4473-A9CC-E61B4654098C Q38166980-8E436060-570E-4753-851B-25357033E4E9 Q38900380-35A8C41F-26F8-4CFC-B35F-E591E16F998C Q39623697-EC6140C3-3EDB-4483-BA9D-3A57F4122E9D Q39753374-B2A35818-14F8-435F-BABD-D8D437A4A095 Q42621214-793D2C31-818D-4495-B677-042BACA48DCC Q44387606-B3A97735-7EAA-4956-9840-BF746742EBEF Q46175467-B7A812DC-8C26-45F8-8311-09F7FB09F573 Q47687584-2B5A6FA4-5643-408B-BF7D-3C95162BE7D1 Q48136353-E05EB38E-18E1-4DE3-9543-3826FAF6F939 Q48544553-50CD5454-3A40-4332-99E0-B59F3ABD061B Q48738832-AA5CC4D8-C2A6-4263-8B0F-7010FD9564EA Q52661554-6DAEDEDA-A1CF-4AD4-9EC1-C86726CA377B Q53784459-990B5E42-3C1A-4B62-93E8-ACE1F162ACEB Q55265817-4687C218-C18A-4BCA-BDC6-6ECDACEFEBCA

P2860

Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals.

http://www.wikidata.org/entity/Q31097762

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Functionalized bis(thiosemicar ...... specific radiopharmaceuticals.

@ast

Functionalized bis(thiosemicar ...... specific radiopharmaceuticals.

@en

type

label

Functionalized bis(thiosemicar ...... specific radiopharmaceuticals.

@ast

Functionalized bis(thiosemicar ...... specific radiopharmaceuticals.

@en

prefLabel

Functionalized bis(thiosemicar ...... specific radiopharmaceuticals.

@ast

Functionalized bis(thiosemicar ...... specific radiopharmaceuticals.

@en

P1433

Q31097762-CBD0FB90-D798-46D6-99BC-5FB95407076F

P1476

Q31097762-5DC98E47-5752-4A64-91D2-6D6F423DCBDB

P2093

Q31097762-088973A7-0763-4D73-99DA-3CFA5DD40899

Q31097762-24105F74-20B4-4C7A-AB75-9B186E3E7BBA

Q31097762-340C4455-B328-4149-882C-25D905E6AFF8

Q31097762-50454845-3AAA-485A-BF14-8F56487CE1B1

Q31097762-61E5987A-37F5-4925-B4B8-8871102F90CE

Q31097762-68A79D47-0060-44FA-A371-88074B13DA5B

Q31097762-74F5DFDF-8BF7-4860-8033-FBAE306D8B42

Q31097762-832E4504-601A-4605-B944-795B57338474

Q31097762-94CDA44B-D5F0-4251-8E24-8B0883C44CA1

Q31097762-9CFF9F81-4911-4C81-BDDD-E06A02AB988B

P304

Q31097762-2AD98FB8-E8E1-4605-AF16-A5AC7CE54638

P31

Q31097762-F7E956A7-F348-40A5-9A4E-0B039539AFD9

P356

Q31097762-04ADB669-51D1-4BB5-9DE2-7ECC3ED5BC19

P407

Q31097762-2D0214D9-B417-4E35-BBB4-702C45DE5FDF

P433

Q31097762-34A401C3-AE83-45FB-9154-36DFBEBEBE8D

P478

Q31097762-60D133A6-BFB4-4CCD-883A-71152DA52EDC

P50

Q31097762-894FD5B5-39D4-401F-AB4C-604F90408D23

Q31097762-A8727E72-0079-412B-932F-75B974263170

Q31097762-CF05473E-79D3-4482-A610-2FA3CE44E43E

P577

Q31097762-415D0490-BBD4-4519-9FD2-96AC13EAA577

P5875

Q31097762-A9928A38-C6B6-429F-BE2D-F128DB8DF3D3

P698

Q31097762-ACDB9D16-C921-4441-B9CB-24A0245168C0

P356

P1433

Inorganic Chemistry

P1476

Functionalized bis(thiosemicar ...... -specific radiopharmaceuticals

@en

P2093

Andrew R Cowley

http://www.w3.org/2001/XMLSchema#string

Franklin I Aigbirhio

http://www.w3.org/2001/XMLSchema#string

Grant C Churchill

http://www.w3.org/2001/XMLSchema#string

Helen M Betts

http://www.w3.org/2001/XMLSchema#string

Jennifer C Green

http://www.w3.org/2001/XMLSchema#string

Jonathan R Dilworth

http://www.w3.org/2001/XMLSchema#string

Josephine M Peach

http://www.w3.org/2001/XMLSchema#string

Martin Christlieb

http://www.w3.org/2001/XMLSchema#string

Paul Burke

http://www.w3.org/2001/XMLSchema#string

Paul D Bonnitcha

http://www.w3.org/2001/XMLSchema#string

P304

465-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/IC0615628

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Jason P. Holland

Sridhar R. Vasudevan

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6524590

http://www.w3.org/2001/XMLSchema#string

P698

17279826

http://www.w3.org/2001/XMLSchema#string